Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient

Journal of Medical Microbiology

Volumn 61, Issue PART 11, 2012, Pages 1617-1620

  Cosson, Marie Anne ^a,b   Bertrand, Jean Baptiste ^a,b   Martin, Clémence ^a,b   Veziris, Nicolas ^c,d,e   Picard, Capucine ^a,f,g   Goulvestre, Claire ^b   Coignard, Sophie ^a,b   Benoit, Jean Pierre ^a,b   Silvera, Stéphane ^b   Moro, Marie Rose ^a,b   Poyart, Claire ^a,b,h   Morand, Philippe C ^a,b,h  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Assistance Publique Hôpitaux de Paris ^*  (France)

^c SORBONNE UNIVERSITÉ   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e Centre National de Reference des Mycobacteries   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g INSERM   (France)

^h INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANOREXIA NERVOSA; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LABORATORY TEST; LUNG INFECTION; LUNG TUBERCULOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUBERCULIN TEST;

ANOREXIA NERVOSA; ANTIBODIES, BACTERIAL; ANTITUBERCULAR AGENTS; ETHAMBUTOL; FEMALE; HUMANS; INTERFERON-GAMMA; ISONIAZID; LUNG DISEASES; LYMPHOCYTES; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM KANSASII; RIFAMPIN; YOUNG ADULT;

EID: 84867503972     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.042739-0     Document Type: Article

References (23)

1. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision. Washington, DC: American Psychiatric Association.
2. Antoine, D. & Che, D. (2012). Tuberculosis cases reported in France in 2010. Bulletin Epidémiologique Hebdomadaire, 285-287.
3. Arend, S. M., de Haas, P., Leyten, E., Rosenkrands, I., Rigouts, L., Andersen, P., Mijs, W., van Dissel, J. T. & van Soolingen, D. (2005). ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii. J Infect Dis 191, 1301-1310.
4. Bocchino, M., Chairadonna, P., Matarese, A., Bruzzese, D., Salvatores, M., Tronci, M., Moscariello, E., Galati, D., Alma, M. G. & other authors (2010). Limited usefulness of QuantiFERON-TB Gold In-Tube for monitoring anti-tuberculosis therapy. Respir Med 104, 1551-1556.
5. Bowers, T. K. & Eckert, E. (1978). Leukopenia in anorexia nervosa. Lack of increased risk of infection. Arch Intern Med 138, 1520-1523.
6. Brown, R. F., Bartrop, R., Beumont, P. & Birmingham, C. L. (2005). Bacterial infections in anorexia nervosa: delayed recognition increases complications. Int J Eat Disord 37, 261-265.
7. Carrara, S., Vincenti, D., Petrosillo, N., Amicosante, M., Girardi, E. & Goletti, D. (2004). Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 38, 754-756.
8. Chiappini, E., Fossi, F., Bonsignori, F., Sollai, S., Galli, L. & de Martino, M. (2012). Utility of interferon-c release assay results to monitor anti-tubercular treatment in adults and children. Clin Ther 34, 1041-1048.
9. Devulder, G., Pé rouse de Montclos, M. & Flandrois, J. P. (2005). A multigene approach to phylogenetic analysis using the genus Mycobacterium as a model. Int J Syst Evol Microbiol 55, 293-302.
10. Ewer, K., Millington, K. A., Deeks, J. J., Alvarez, L., Bryant, G. & Lalvani, A. (2006). Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174, 831-839.
11. Feinberg, J., Fieschi, C., Doffinger, R., Feinberg, M., Leclerc, T., Boisson-Dupuis, S., Picard, C., Bustamante, J., Chapgier, A. & other authors (2004). Bacillus Calmette Guérin triggers the IL-12/IFN-c axis by an IRAK-4-and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol 34, 3276-3284.
12. Gey van Pittius, N. C., Sampson, S. L., Lee, H., Kim, Y., van Helden, P. D. & Warren, R. M. (2006). Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol Biol 6, 95.
13. Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G. & other authors (2007). An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175, 367-416.
14. Hü tter, G., Ganepola, S. & Hofmann, W. K. (2009). The hematology of anorexia nervosa. Int J Eat Disord 42, 293-300.
15. Katiyar, S. K., Sampath, A., Bihari, S., Mamtani, M. & Kulkarni, H. (2008). Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 12, 1146-1152.
16. Kobashi, Y., Mouri, K., Miyashita, N. & Oka, M. (2009a). Clinical usefulness of QuantiFERON TB-2G test for the early diagnosis of pulmonary Mycobacterium kansasii disease. Jpn J Infect Dis 62, 239-241.
17. Kobashi, Y., Mouri, K., Yagi, S., Obase, Y., Miyashita, N., Okimoto, N., Matsushima, T., Kageoka, T. & Oka, M. (2009b). Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis 13, 1422-1426.
18. Mori, T. (2009). Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother 15, 143-155.
19. Pai, M., Joshi, R., Dogra, S., Mendiratta, D. K., Narang, P., Dheda, K. & Kalantri, S. (2006). Persistently elevated T cell interferon-c responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol 1, 7.
20. Pertschuk, M. J., Crosby, L. O., Barot, L. & Mullen, J. L. (1982). Immunocompetency in anorexia nervosa. Am J Clin Nutr 35, 968-972.
21. Shitrit, D., Priess, R., Peled, N., Bishara, G., Shlomi, D. & Kramer, M. R. (2007). Differentiation of Mycobacterium kansasii infection from Mycobacteriumtuberculosis infection: comparison of clinical features, radiological appearance, and outcome. Eur J Clin Microbiol Infect Dis 26, 679-684.
22. van Ingen, J., de Zwaan, R., Dekhuijzen, R., Boeree, M. & van Soolingen, D. (2009). Region of difference 1 in nontuberculous Mycobacterium species adds a phylogenetic and taxonomical character. J Bacteriol 191, 5865-5867.
23. van Zyl-Smit, R. N., Zwerling, A., Dheda, K. & Pai, M. (2009). Withinsubject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE 4, e8517.